I doubt it will have any effect on approval
Post# of 148175
We have the FDA's guidelines to fulfill, which is well over 300 patients, and while it would be terrific for the trial to be cut short on good results, I wouldn't count on it and certainly not with the relatively small amount of patients we've injected so far.